Form 4 for RMTI ROCKWELL MEDICAL, INC.
Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-17 · accession 0001104659-23-035195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-21 | 2023-03-17 | RMTI | TIMMINS MEGAN C. | EVP, CLO, Sec | A - Grant | $0.00 | +28.5K | 28.5K | New | $0 |
| D | 2023-03-21 | 2022-03-17 | RMTI | TIMMINS MEGAN C. | EVP, CLO, Sec | A - Grant | $0.00 | +37.2K | 37.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-17 | A | A | 28,515 | $0.00 | 28,515 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-17 | A | A | 37,210 | $0.00 | 37,210 | D | $1.37 · — to 2033-03-17 | 37,210 Common Stock | (F2) Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. |